Symptoms and quality of life in patients with coexistent atrial fibrillation and atrial flutter

IntroductionPersonal digital devices that provide health information, such as the Apple Watch, have developed an increasing array of cardiopulmonary tracking features which have received regulatory clearance and are directly marketed to consumers. Despite their widespread and increasing use, data about the impact of personal digital device use on patient-reported outcomes and healthcare utilisation are sparse. Among a population of patients with atrial fibrillation and/or atrial flutter undergoing cardioversion, our primary aim is to determine the impact of the heart rate measurement, irregular rhythm notification, and ECG features of the Apple Watch on quality of life and healthcare utilisation.Methods and analysisWe are conducting a prospective, open-label multicentre pragmatic randomised clinical trial, leveraging a unique patient-centred health data sharing platform for enrolment and follow-up. A total of 150 patients undergoing cardioversion for atrial fibrillation or atrial flutter will be randomised 1:1 to receive the Apple Watch Series 6 or Withings Move at the time of cardioversion. The primary outcome is the difference in the Atrial Fibrillation Effect on QualiTy-of-life global score at 6 months postcardioversion. Secondary outcomes include inpatient and outpatient healthcare utilisation. Additional secondary outcomes include a comparison of the Apple Watch ECG and pulse oximeter features with gold-standard data obtained in routine clinical care settings.Ethics and disseminationThe Institutional Review Boards at Yale University, Mayo Clinic, and Duke University Health System have approved the trial protocol. This trial will provide important data to policymakers, clinicians and patients about the impact of the heart rate, irregular rhythm notification, and ECG features of widely used personal digital devices on patient quality of life and healthcare utilisation. Findings will be disseminated to study participants, at professional society meetings and in peer-reviewed journals.Trial registration numberNCT04468321

Download Full-text

EHRA classes, additional cardiovascular risk and quality of life in patients during the first six months of atrial flutter and atrial fibrillation radiofrequency

Zaporozhye Medical Journal ◽

10.14739/2310-1210.2018.3.132107 ◽

2018 ◽

Vol 0 (3) ◽

Author(s):

M. S. Brynza ◽

M. I. Yabluchanskіy

Keyword(s):

Quality Of Life ◽

Atrial Fibrillation ◽

Cardiovascular Risk ◽

Atrial Flutter

Download Full-text

Long-term results of simultaneous hybrid ablation of therapy-resistant atrial fibrillation

European Heart Journal ◽

10.1093/ehjci/ehaa946.0626 ◽

2020 ◽

Vol 41 (Supplement_2) ◽

Author(s):

A Baimbetov ◽

K Bizhanov ◽

I Yakupova ◽

B Bairamov ◽

U Medeubekov ◽

...

Keyword(s):

Quality Of Life ◽

Atrial Fibrillation ◽

Sinus Rhythm ◽

Left Atrium ◽

Atrial Flutter ◽

Pulmonary Veins ◽

Long Term Results ◽

Hybrid Ablation

Abstract Background A hybrid technique using thoracoscopic epicardial and standard endocardial ablation of atrial fibrillation (AF) is a strategy used to treat AF patients with therapy-resistant symptomatic AF. We conducted comparative study of efficacy and safety of simultaneous hybrid ablation in patients with non-paroxysmal forms of AF and evaluated the factors that determine success and quality of life. Methods The study included 56 consecutive patients who underwent simultaneous hybrid ablation. First, epicardial ablation was performed using thoracoscopic access: to isolate the pulmonary veins and the posterior wall of the left atrium. After this, an endocardial electrophysiological assessment was carried out from the pulmonary veins to the left atrium and additional endocardial ablation was performed, where necessary. The next day, a loop ECG recorder was implanted subcutaneously in the thoracic region. Efficiency was evaluated using implanted loop ECG recorders. The average follow up was 24 months, the studied patients came to the clinic every 3 months to receive diagnostic reports from loop recorders. Recurrence was defined as AF, atrial flutter and other atrial tachycardia, recorded in reports of loop recorders lasting >30 sec during follow up period. Results Continuous follow up was carried out in 56 patients, the average age of which was 57±9 years. Of these, 39 (70%) men, 6 (10%) paroxysmal, 38 (68%) persistent and 12 (22%) long-standing persistent AF. Within 24 months of follow up, 45 (80%) maintened a sinus rhythm. Most recurrenses were atrial flutter (8/11 patients). Success was associated with factors such as left atrial size, patient age and duration of arrhythmia. Patients with paroxysmal AF had the highest success, patients with long-standing persistent AF had the least success. 5 (9%) patients had complications associated with the procedure. Quality of life after ablation improved in patients with sinus rhythm. Conclusion The efficiency of simultaneuous hybrid AF ablation was 80% for 24 months of continuous follow up period associated with the type of AF. Quality of life improved significantly, complications associated with the procedure occurred in 9%. Funding Acknowledgement Type of funding source: None

Download Full-text

P-332 Quality of life in patients with common atrial flutter and atrial fibrillation underwent rfa of inferior isthmus using low rate irrigation technique

EP Europace ◽

10.1016/s1099-5129(03)92081-2 ◽

2003 ◽

Vol 4 ◽

pp. B144

Author(s):

A ARDASHEV

Keyword(s):

Quality Of Life ◽

Atrial Fibrillation ◽

Atrial Flutter ◽

Low Rate

Download Full-text

Symptomatic improvement after radiofrequency catheter ablation for typical atrial flutter

Heart ◽

10.1136/hrt.86.2.167 ◽

2001 ◽

Vol 86 (2) ◽

pp. 167-171

Author(s):

P A O'Callaghan ◽

M Meara ◽

E Kongsgaard ◽

J Poloniecki ◽

L Luddington ◽

...

Keyword(s):

Quality Of Life ◽

Atrial Fibrillation ◽

Atrial Flutter ◽

Time Interval ◽

Typical Atrial Flutter ◽

Symptom Severity Score ◽

Symptom Frequency ◽

Atrial Flutter Ablation ◽

Frequency Score

OBJECTIVETo assess the changes in quality of life, arrhythmia symptoms, and hospital resource utilisation following catheter ablation of typical atrial flutter.DESIGNPatient questionnaire to compare the time interval following ablation with a similar time interval before ablation.SETTINGTertiary referral centre.PATIENTS63 consecutive patients were studied. Four patients subsequently underwent an ablate and pace procedure, two died of co-morbid illnesses, and two were lost to follow up. The remaining 55 patients form the basis of the report.RESULTSPatients were followed for a mean (SD) of 12 (9.5) months. Atrial flutter ablation resulted in an improvement in quality of life (3.8 v 2.5, p < 0.001) and reductions in symptom frequency score (2.0v 3.5, p < 0.001) and symptom severity score (2.0 v 3.8, p < 0.001) compared with preablation values. There was a reduction in the number of patients visiting accident and emergency departments (11%v 53%, p < 0.001), requiring cardioversion (7% v 51%, p < 0.001), or being admitted to hospital for a rhythm problem (11%v 56%, p < 0.001). Subgroup analysis confirmed that patients with atrial flutter and concomitant atrial fibrillation before ablation and those with atrial flutter alone both derived significant benefit from atrial flutter ablation. Patients with concomitant atrial fibrillation had an improvement in quality of life (3.5 v 2.5, p < 0.001) and reductions in symptom frequency score (2.3 v 3.5, p < 0.001) and symptom severity score (2.2v 3.7, p < 0.001) compared with preablation values.CONCLUSIONSAblation of atrial flutter is recommended both in patients with atrial flutter alone and in those with concomitant atrial fibrillation.

Download Full-text